Money will be used to expand the firm's platform of polymers across various therapeutic fields, including nerve repair, cardiovascular and gastroenterology.
The final quarter of 2019 has begun, which means Congress and the Trump Administration are hard at work finalizing healthcare initiatives before year's end.
Jeffrey J. Kimbell, David C. Rudloff and Caroline P. Tucker, Jeffrey J. Kimbell & Associates Inc.11.04.19